The role of integrins in tumor angiogenesis

被引:88
作者
Hwang, R
Varner, J
机构
[1] Univ Calif San Diego, Dept Med, Moores Comprehens Canc Ctr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Surg, Moores Comprehens Canc Ctr, La Jolla, CA 92093 USA
关键词
D O I
10.1016/j.hoc.2004.09.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Integrins are cell adhesion molecules that play an important role in the regulation of angiogenesis. In this overview, the vascular integrins and their mechanisms of action are outlined. Integrins have been evaluated in preclinical and clinical studies for the treatment of cancer and as diagnostic markers of angiogenesis. Furthermore, integrins are the basis for targeted therapy for solid tumors and novel imaging techniques to assess the angiogenic response of tumors.
引用
收藏
页码:991 / +
页数:17
相关论文
共 79 条
[51]  
2-I
[52]   Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors [J].
Miyamoto, S ;
Teramoto, H ;
Gutkind, JS ;
Yamada, KM .
JOURNAL OF CELL BIOLOGY, 1996, 135 (06) :1633-1642
[53]   alpha v Integrins as receptors for tumor targeting by circulating ligands [J].
Pasqualini, R ;
Koivunen, E ;
Ruoslahti, E .
NATURE BIOTECHNOLOGY, 1997, 15 (06) :542-546
[54]  
Patel SR, 2001, CANCER, V92, P1347, DOI 10.1002/1097-0142(20010901)92:5<1347::AID-CNCR1456>3.0.CO
[55]  
2-0
[56]   Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2 [J].
Pfeifer, A ;
Kessler, T ;
Silletti, S ;
Cheresh, DA ;
Verma, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12227-12232
[57]  
PIZZOLATO J, 2003, P AM SOC CLIN ONCOL
[58]   Ligand binding to integrins [J].
Plow, EF ;
Haas, TK ;
Zhang, L ;
Loftus, J ;
Smith, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) :21785-21788
[59]   A pilot trial of vitaxin, a humanized anti-vitronectin receptor (anti αvβ3) antibody in patients with metastatic cancer [J].
Posey, JA ;
Khazaeli, MB ;
DelGrosso, A ;
Saleh, MN ;
Lin, CY ;
Huse, W ;
LoBuglio, AF .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2001, 16 (02) :125-132
[60]  
Pozzi M, 1998, J CELL BIOL, V142, P587